These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 37138385)

  • 1. Pre-treatment bicarbonate levels and decongestion by acetazolamide: the ADVOR trial.
    Martens P; Verbrugge FH; Dauw J; Nijst P; Meekers E; Augusto SN; Ter Maaten JM; Heylen L; Damman K; Mebazaa A; Filippatos G; Ruschitzka F; Tang WHW; Dupont M; Mullens W
    Eur Heart J; 2023 Jun; 44(22):1995-2005. PubMed ID: 37138385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decongestion With Acetazolamide in Acute Decompensated Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction: A Prespecified Analysis From the ADVOR Trial.
    Martens P; Dauw J; Verbrugge FH; Nijst P; Meekers E; Augusto SN; Ter Maaten JM; Damman K; Mebazaa A; Filippatos G; Ruschitzka F; Tang WHW; Dupont M; Mullens W
    Circulation; 2023 Jan; 147(3):201-211. PubMed ID: 36335479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium and potassium changes during decongestion with acetazolamide - A pre-specified analysis from the ADVOR trial.
    Dhont S; Martens P; Meekers E; Dauw J; Verbrugge FH; Nijst P; Ter Maaten JM; Damman K; Mebazaa A; Filippatos G; Ruschitzka F; Tang WHW; Dupont M; Mullens W
    Eur J Heart Fail; 2023 Aug; 25(8):1310-1319. PubMed ID: 37062871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetazolamide in Acute Decompensated Heart Failure with Volume Overload.
    Mullens W; Dauw J; Martens P; Verbrugge FH; Nijst P; Meekers E; Tartaglia K; Chenot F; Moubayed S; Dierckx R; Blouard P; Troisfontaines P; Derthoo D; Smolders W; Bruckers L; Droogne W; Ter Maaten JM; Damman K; Lassus J; Mebazaa A; Filippatos G; Ruschitzka F; Dupont M;
    N Engl J Med; 2022 Sep; 387(13):1185-1195. PubMed ID: 36027559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristics.
    Mullens W; Dauw J; Martens P; Meekers E; Nijst P; Verbrugge FH; Chenot F; Moubayed S; Dierckx R; Blouard P; Derthoo D; Smolders W; Ector B; Hulselmans M; Lochy S; Raes D; Van Craenenbroeck E; Vandekerckhove H; Hofkens PJ; Goossens K; Pouleur AC; De Ceuninck M; Gabriel L; Timmermans P; Prihadi EA; Van Durme F; Depauw M; Vervloet D; Viaene E; Vachiery JL; Tartaglia K; Ter Maaten JM; Bruckers L; Droogne W; Troisfontaines P; Damman K; Lassus J; Mebazaa A; Filippatos G; Ruschitzka F; Dupont M
    Eur J Heart Fail; 2022 Sep; 24(9):1601-1610. PubMed ID: 35733283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Chloride and the Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload: A Post Hoc Analysis From the ADVOR Trial.
    Van den Eynde J; Martens P; Dauw J; Nijst P; Meekers E; Ter Maaten JM; Damman K; Filippatos G; Lassus J; Mebazaa A; Ruschitzka F; Dupont M; Mullens W; Verbrugge FH
    Circ Heart Fail; 2024 Oct; 17(10):e011749. PubMed ID: 39171394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial.
    Mullens W; Verbrugge FH; Nijst P; Martens P; Tartaglia K; Theunissen E; Bruckers L; Droogne W; Troisfontaines P; Damman K; Lassus J; Mebazaa A; Filippatos G; Ruschitzka F; Dupont M
    Eur J Heart Fail; 2018 Nov; 20(11):1591-1600. PubMed ID: 30238574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance.
    Verbrugge FH; Martens P; Ameloot K; Haemels V; Penders J; Dupont M; Tang WHW; Droogné W; Mullens W
    Eur J Heart Fail; 2019 Nov; 21(11):1415-1422. PubMed ID: 31074184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natriuretic Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload.
    Verbrugge FH; Martens P; Dauw J; Nijst P; Meekers E; Augusto SN; Ter Maaten JM; Damman K; Filippatos G; Lassus J; Mebazaa A; Ruschitzka F; Dupont M; Mullens W
    J Am Coll Cardiol; 2023 May; 81(20):2013-2024. PubMed ID: 37197845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal function and decongestion with acetazolamide in acute decompensated heart failure: the ADVOR trial.
    Meekers E; Dauw J; Martens P; Dhont S; Verbrugge FH; Nijst P; Ter Maaten JM; Damman K; Mebazaa A; Filippatos G; Ruschitzka F; Tang WHW; Dupont M; Mullens W
    Eur Heart J; 2023 Oct; 44(37):3672-3682. PubMed ID: 37623428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similarities and distinctions between acetazolamide and sodium-glucose cotransporter 2 inhibitors in patients with acute heart failure: Key insights into ADVOR and EMPULSE.
    Packer M; Butler J
    Eur J Heart Fail; 2023 Sep; 25(9):1537-1543. PubMed ID: 37403655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considering Addition of Acetazolamide to Loop Diuretics as Treatment for Acute Heart Failure: ADVOR Reappraisal.
    Greene SJ; Felker GM
    JACC Heart Fail; 2023 Mar; 11(3):365-367. PubMed ID: 36889884
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combination diuretic therapy in heart failure].
    Massop K; Kramers CK
    Ned Tijdschr Geneeskd; 2023 May; 167():. PubMed ID: 37257097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tackling Congestion in Acute Heart Failure: Is It the Primetime for "Combo Diuretic Therapy?".
    Kazory A; Ronco C
    Cardiorenal Med; 2023; 13(1):184-188. PubMed ID: 36787714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing intrinsic renal sodium avidity in acute heart failure: implications in predicting and guiding decongestion.
    Martens P; Chen HH; Verbrugge FH; Testani JT; Mullens W; Tang WHW
    Eur J Heart Fail; 2022 Oct; 24(10):1978-1987. PubMed ID: 36054180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants and impact of the natriuretic response to diuretic therapy in heart failure with reduced ejection fraction and volume overload.
    Verbrugge FH; Dupont M; Bertrand PB; Nijst P; Penders J; Dens J; Verhaert D; Vandervoort P; Tang WH; Mullens W
    Acta Cardiol; 2015 Jun; 70(3):265-73. PubMed ID: 26226699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In acute decompensated HF, adding acetazolamide to IV loop diuretics reduced congestion at 3 d across eGFR levels.
    Rospert D; Molony DA
    Ann Intern Med; 2024 Jan; 177(1):JC2. PubMed ID: 38163366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study.
    Dauw J; Lelonek M; Zegri-Reiriz I; Paredes-Paucar CP; Zara C; George V; Cobo-Marcos M; Knappe D; Shchekochikhin D; Lekhakul A; Klincheva M; Frea S; Miró Ò; Barker D; Borbély A; Nasr S; Doghmi N; de la Espriella R; Singh JS; Bovolo V; Fialho I; Ross NT; van den Heuvel M; Benkouar R; Findeisen H; Alhaddad IA; Al Balbissi K; Barge-Caballero G; Ghazi AM; Bruckers L; Martens P; Mullens W
    ESC Heart Fail; 2021 Dec; 8(6):4685-4692. PubMed ID: 34708555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new role for an old drug: acetazolamide in decompensated heart failure.
    Doggrell SA
    Expert Opin Pharmacother; 2023 Feb; 24(3):309-313. PubMed ID: 36562420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocolized Natriuresis-Guided Decongestion Improves Diuretic Response: The Multicenter ENACT-HF Study.
    Dauw J; Charaya K; Lelonek M; Zegri-Reiriz I; Nasr S; Paredes-Paucar CP; Borbély A; Erdal F; Benkouar R; Cobo-Marcos M; Barge-Caballero G; George V; Zara C; Ross NT; Barker D; Lekhakul A; Frea S; Ghazi AM; Knappe D; Doghmi N; Klincheva M; Fialho I; Bovolo V; Findeisen H; Alhaddad IA; Galluzzo A; de la Espriella R; Tabbalat R; Miró Ò; Singh JS; Nijst P; Dupont M; Martens P; Mullens W
    Circ Heart Fail; 2024 Jan; 17(1):e011105. PubMed ID: 38179728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.